UMC Governing Board Audit & Finance Committee
Summary
SWB $8M over budget, contract labor high, liquidity 64 days cash.
What Matters to Employees 2 items
Leading clinical trial site; financial benefits shown.
Medicaid dis-enrollment risk, $150M outstanding payments.
All Agenda Items 22 items
On track; budget details discussed; risk mitigation in place.
Savings above target, but $900K off-contract spend.
Revenue up $12.2M, but SWB $8M over, contract labor high.
Admissions -9.5%; labor +$7.7M; cash on hand 54.1 days.
No impact to UMC; private hospitals may face 15% fee.
Extends agreement, adds performance incentive.
Ratification for anesthesia/ortho reimbursement.
Updates billing forms, no major changes.
Adds orthopedic and anesthesia professional fees.
Extends term 3 years, updates rates.
Extends term 24 months; updates reimbursement.
Adds ortho and anesthesia services.
Adds orthopedic and anesthesia professional services.
Consulting for Magnet designation, 2-year term.
Extends term; increases NTE for renovation projects.
Adds cleaning systems for ORs.
Sole respondent; 3-year term with extensions.
Extends 2 years, increases funding for patient days.
Increases funding for pest control at new locations.
Approval to purchase property; closing pending.
Adds pancreas transplant; increases funding due to volume.
Additional space, parking, extended term to 2028.